Short-term TNF-alpha inhibition reduces short-term and long-term inflammatory changes post-ischemia/reperfusion in rat intestinal transplantation

Transplantation

Volumn 97, Issue 7, 2014, Pages 732-739

  Gerlach, Undine A ^a   Atanasov, Georgi ^b   Wallenta, Leah ^a   Polenz, Dietrich ^a   Reutzel Selke, Anja ^a   Kloepfel, Maren ^a   Jurisch, Anke ^a   Marksteiner, Marion ^a   Loddenkemper, Christoph ^a   Neuhaus, Peter ^a   Sawitzki, Birgit ^a   Pascher, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Department of Visceral Transplantation Thoracic and Vascular Surgery Universitaetsklinik Leipzig ^*  (Germany)

Author keywords

Infliximab; Intestinal transplantation; Ischemia reperfusion injury; TNF inhibition

Indexed keywords

ETANERCEPT; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLIXIMAB; LIPOPOLYSACCHARIDE BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL PROTECTION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INTESTINE TRANSPLANTATION; LONG TERM SURVIVAL; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MONOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SURVIVAL RATE; T LYMPHOCYTE; TREATMENT DURATION;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CARRIER PROTEINS; INFLAMMATION; INTESTINES; LUNG; MALE; MEMBRANE GLYCOPROTEINS; NEUTROPHIL INFILTRATION; RATS; RATS, INBRED LEW; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897576866     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000032     Document Type: Article

References (33)

1. http://intestinaltransplantassociation.com/?cat=14; last accessed: 20.03.2013.
2. Pascher A, Kohler S, Neuhaus P, et al. Present status and future perspectives of intestinal transplantation. Transpl Int 2008; 21: 401. Epub 2008 Feb 18.
3. Fishbein T, Novitskiy G, Mishra L, et al. NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut 2008; 57: 323.
4. Janse M, Weersma RK, Sudan DL, et al. Association of Crohn's disease-associated NOD2 variants with intestinal failure requiring small bowel transplantation and clinical outcomes. Gut 2010; 60: 877.
5. Ningappa M, Higgs BW, Weeks DE, et al. NOD2 gene polymorphism rs2066844 associates with need for combined liver-intestine transplantation in children with sort-gut syndrome. Am J Gastroenetrol 2010; 106: 157.
6. Gerlach UA, Koch M, Müller HP, et al. Tumor necrosis factor alpha inhibitors as immunomodulatory antirejection agents after intestinal transplantation. Am J Transplant 2011; 11: 1041.
7. Mallick IH, Yang W, Winslet MC, et al. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 2004; 49: 1359.
8. Pascher A, Klupp J. Biologics in the treatment of transplant rejection and ischemia/reperfusion injury: new applications for TNFalpha inhibitors? BioDrugs 2005; 19: 211.
9. Schaefer N, Tahara K, Websky M, et al. Acute rejection and the muscularis propria after intestinal transplantation: the alloresponse, inflammation, and smooth muscle function. Transplantation 2008; 85: 1465.
10. Pech T, von Websky M, Ohsawa I, et al. Intestinal regeneration, residual function and immunological priming following rescue therapy after rat small bowel transplantation. Am J Transplant 2012; 12: 9.
11. Pech T, Finger T, Fujishiro J, et al. Perioperative infliximab application ameliorates acute rejection associated inflammation after intestinal transplantation. Am J Transplant 2010; 10: 2431.
12. Pech T, Jujishiro J, Finger T, et al. Combination therapy of tacrolimus and infliximab reduces inflammatory response and dysmotility in experimental small bowel transplantation in rats. Transplantation 2012; 93: 249.
13. Reutzel-Selke A, Hartmann J, Pratschke J, et al. Cold ischemia does not interfere with tolerance induction. Transplantation 2009; 87: 1116.
14. Miller EA, Ernst JD. Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed. JCI 2009; 119: 1079.
15. Yamashita M, Schmid RA, Okabayashi K, et al. Pentoxifylline in flush solution improves early lung allograft function. Ann Thorac Surg 1996; 61: 1055.
16. Tracey D, Klareskog L, Sasso EH, et al. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 2008; 117: 244.
17. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginaldose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
18. Choi DE, Jeong JY, Lim BJ, et al. Pretreatment with the tumor necrosis factor-alpha blocker etanercept attenuated ischemia-reperfusion renal injury. Transplant Proc 2009; 41: 3590.
19. Langrehr JM, Gube K, Hammer MH, et al. Short-term anti-CD4 plus anti-TNF-alpha receptor treatment in allogeneic small bowel transplantation results in long-term survival. Transplantation 2007; 84: 639.
20. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001; 13: 114.
21. Koca SS, Bahcecioglu IH, Poyrazoglu OK, et al. The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionineand choline-deficient diet. Inflammation 2008; 31: 91.
22. Boettger MK, Hensellek S, Richter F, et al. Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigeninduced arthritis: evidence of a neuronal target. Arthritis Rheum 2008; 58: 2368.
23. Wollin M, Abele S, Bruns H, et al. Inhibition of TNF-alpha reduces transplant arteriosclerosis in a murine aortic transplant model. Transpl Int 2009; 22: 342.
24. Ma H, Wang J, Wang J, et al. Features of chronic allograft rejection on rat small intestine transplantation. Pediatr Transplant 2007; 11: 165.
25. Eugui EM. Fibrogenesis in chronic allograft rejection: underlying mechanisms and pharmacological control. Transplant Proc 2002; 34: 2867.
26. Chen Y, Voegeli TS, Liu PP, et al. Heat shock paradox and a new role of heat shock proteins and their receptors as anti-inflammation targets. Inflamm Allergy Drug Targets 2007; 6: 91.
27. Long SM, Laubach VE, Tribble CG, et al. Pyrrolidine dithiocarbamate reduces lung reperfusion injury. J Surg Res 2003; 112: 12.
28. Fleming SD, Starnes BW, Kiang JG, et al. Heat stress protection against mesenteric I/R-induced alterations in intestinal mucosa in rats. J Appl Physiol 2002; 92: 2600.
29. Kimizuka K, Nakao A, Nalesnik MA, et al. Exogenous IL6 inhibits acute inflammatory responses and prevents ischemia/reperfusion injury after intestinal transplantation. Am J Transplant 2004; 4: 482.
30. Kang SM, Tang Q, Bluestone JA. CD4+CD25+ regulatory T-cells in transplantation: progress, challenges and prospects. Am J Transplant 2007; 7: 1457.
31. Gong W, Klöpfel M, Reutzel-Selke A, et al. High weight differences between donor and recipient affect early kidney graft functionVa role for enhanced IL6 signaling. Am J Transplant 2009; 9: 1742.
32. Peng XX, Currin RT, Thurman RG, et al. Protection by pentoxifylline against normothermic liver IR in rats. Transplantation 1995; 59: 1537.
33. Park PO, Haglund U, Bulkley GB, et al. The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. Surgery 1990; 107: 574.